View Challenges as a Path to Learning and Growth

Christina Bodurow tells us to embrace career challenges, rather than fear them
Industry Matters Newsletter
Woman dressed in business casual, looking at an abstract illustration of a career pathway
Image credit: iStock by Getty Images

Many of us in the science community have been faced with unprecedented changes in our professional and personal lives. The freedoms and routines seminal to the research, discovery, development and commercialization of technology advancement were completely turned upside down. How do you feel about all that just now?

Consider how much your point of view or perspective is influencing how to move forward with career and personal decisions. Rather than feeling that the changes that have been experienced are constraints or setbacks, what if they were embraced as the biggest learning opportunity you’ve ever had? Science and chemistry have adapted, and brought forward new ways of doing laboratory and collaborative research that were unthinkable even three years ago.

Carol Dweck, in her book "Mindset," advocates for consideration of life's lessons, including major challenges, as the path for learning and growth. As you look forward to the next few years of your career, what are your greatest opportunities to adapt and grow to be the best chemistry professional you can be?


Christina Bodurow, Ph.D., Deputy Director and Chief Operating Officer, AViDD, Stanford University School of Medicine
Christina Bodurow, Ph.D., Deputy Director and Chief Operating Officer, AViDD, Stanford University School of Medicine

Christina Bodurow, Ph.D. is a member of the ACS Board of Directors representing District II. She received a B.A. from Kalamazoo College and a Ph.D in Organic Chemistry from Princeton University. She spent more than 30 years at Eli Lilly and Company in multiple medicine development roles. She then took the role of Vice-President of Global Regulatory Affairs for IQVIA for the past 3.5 years, and has just taken on a new role as Deputy Director and Chief Operating Officer at the Stanford Medical School for the AVIDD program (Anti-viral in Drug Discovery and Development).

The opinions expressed in this article are the author's own and do not necessarily reflect the view of their employer or the American Chemical Society.

Christina Bodurow

Christina Bodurow, Ph.D. has just taken on a new role as Deputy Director and Chief Operating Officer at the Stanford Medical School for the AVIDD program (Anti-viral in Drug Discovery and Development).


Related Content